QC
DNA icon

QCM Cayman’s Ginkgo Bioworks DNA Stock Holding History

QCM Cayman’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-811
Closed -$58.7K – 25
2023
Q3 		$58.7K Buy
811
+293
+57% +$23.4K 0.38% 56
2023
Q2 		$38.6K Sell
518
-406
-44% -$24K 0.23% 56
2023
Q1 		$49.2K Buy
+924
New +$58.6K 0.31% 53
2022
Q3 		– Sell
-726
Closed -$69K – 43
2022
Q2 		$69K Buy
+726
New +$88.5K 1.19% 23

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QCM Cayman's DNA Position: Q4 2023 in Review

QCM Cayman sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 811 shares — an estimated $58.7K sold.

QCM Cayman first reported a position in DNA in Q2 2022 and held it in 4 quarters. The position peaked at $69K in Q2 2022. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • QCM Cayman reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • QCM Cayman sold 811 Ginkgo Bioworks shares in Q4 2023, an estimated $58.7K.
  • QCM Cayman first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 4 quarters.
  • QCM Cayman's Ginkgo Bioworks position peaked at $69K in Q2 2022.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on QCM Cayman's 13F filing for Q4 2023, filed 1 Feb 2024.